FDA Approved Flibanserin for Woman

Taureau

Administrator
Flibanserin, sold under the brand name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder. The medication increases the number of satisfying sexual events per month by about one half over placebo from a starting point of about two to three events

The clinical trials data suggest that flibanserin can take up to four weeks to see results, and up to eight or twelve weeks to see maximum results.

Flibanserin works to raise levels of dopamine and norepinephrine to promote desire and arousal. Thus, one pill targets the physical aspect of sexual dysfunction.
 
Top